Hilde Merete Hagen
General Counsel bei VISTIN PHARMA ASA
Vermögen: 82 675 $ am 31.03.2024
Profil
Hilde Merete Hagen is currently the Vice President of Quality & Regulatory Affairs at Vistin Pharma ASA since 2015.
Prior to this, she held the same position at Pronova BioPharma ASA and Weifa AS.
Hagen is a graduate of the University of Oslo and BI Norwegian Business School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
VISTIN PHARMA ASA
0,09% | 04.07.2023 | 40 000 ( 0,09% ) | 82 675 $ | 31.03.2024 |
Aktive Positionen von Hilde Merete Hagen
Unternehmen | Position | Beginn |
---|---|---|
VISTIN PHARMA ASA | General Counsel | 01.03.2015 |
Ehemalige bekannte Positionen von Hilde Merete Hagen
Unternehmen | Position | Ende |
---|---|---|
Weifa AS
Weifa AS Pharmaceuticals: MajorHealth Technology Weifa AS operates as a pharmaceutical company. The firm supplies non-prescription, over the counter medicines, and lifestyle products. It offers medicines for pain, fever, muscle and joint, colds, wound, as well as vitamins, minerals, and prescription products. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | General Counsel | - |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Corporate Officer/Principal | - |
Ausbildung von Hilde Merete Hagen
University of Oslo | Graduate Degree |
BI Norwegian Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VISTIN PHARMA ASA | Health Technology |
Private Unternehmen | 2 |
---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
Weifa AS
Weifa AS Pharmaceuticals: MajorHealth Technology Weifa AS operates as a pharmaceutical company. The firm supplies non-prescription, over the counter medicines, and lifestyle products. It offers medicines for pain, fever, muscle and joint, colds, wound, as well as vitamins, minerals, and prescription products. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |